StockData
Septerna, Inc. logo

Septerna, Inc. (SEPN) stock

SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30163% above fair value
$38.61−0.59 (-1.51%)

Close on Nov 20, 2026Market cap $1.80BP/E –Yield –

Septerna free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Septerna's free cash flow for the twelve months ending Sep 30, 2026 was -$77.59M, down 175.2% year over year. For fiscal 2025 it was $109.67M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$109.67M–
FY2024Dec 31, 2024-$69.57M–
FY2023Dec 31, 2023-$41.60M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$13.90M-108.2%
Q2 FY2026Jun 30, 2026-$22.18M–
Q1 FY2026Mar 31, 2026-$26.47M–
Q4 FY2025Dec 31, 2025-$15.05M–
Q3 FY2025Sep 30, 2025$168.79M–
Q2 FY2025Jun 30, 2025-$20.35M–
Q1 FY2025Mar 31, 2025-$23.73M–
Q4 FY2024Dec 31, 2024-$21.57M–
Q3 FY2024Sep 30, 2024-$17.39M–
Q2 FY2024Jun 30, 2024-$13.14M–
Q1 FY2024Mar 31, 2024-$17.48M–
Q4 FY2023Dec 31, 2023-$10.04M–

More Septerna figures

See a number that looks wrong?